Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 7/2023

28.11.2022 | Commentary

Pulsed field electroporation for pulmonary vein isolation—continued innovation to improve our atrial fibrillation armamentarium

verfasst von: Robert C. Ward, Christopher V. DeSimone

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Excerpt

Atrial fibrillation (AF) is the most common arrhythmia plaguing our patients. The search for enhanced efficacy and safety in pulmonary vein isolation (PVI) remains an ongoing struggle. Current catheter-based treatment modalities are overwhelmingly thermal based, including radiofrequency (RF) and cryoablation (cryo). These approaches have efficacy concerns related to difficulty in creating contiguous and durable lesions, which leads to PV reconnection and AF recurrence. Thermal ablation also poses a risk for esophageal and phrenic nerve damage. Pulsed field electroporation ablation (PFA) is a novel technique that utilizes short bursts of high voltage. This leads to cellular membrane disruption via pore formation and results in cellular and tissue destruction with enhanced tissue selectivity [1]. Given the potential advantages in both efficacy and safety, there has been a robust effort to design novel catheters and delivery systems to utilize this exciting innovation. …
Literatur
1.
Zurück zum Zitat Maor E, et al. Pulsed electric fields for cardiac ablation and beyond: a state-of-the-art review. Heart Rhythm. 2019;16(7):1112–20.CrossRefPubMed Maor E, et al. Pulsed electric fields for cardiac ablation and beyond: a state-of-the-art review. Heart Rhythm. 2019;16(7):1112–20.CrossRefPubMed
2.
Zurück zum Zitat Sugrue A, et al. Irreversible electroporation for catheter-based cardiac ablation: a systematic review of the preclinical experience. J Interv Card Electrophysiol. 2019;55(3):251–65.CrossRefPubMed Sugrue A, et al. Irreversible electroporation for catheter-based cardiac ablation: a systematic review of the preclinical experience. J Interv Card Electrophysiol. 2019;55(3):251–65.CrossRefPubMed
3.
Zurück zum Zitat Reddy VY, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7(5):614–27.CrossRefPubMed Reddy VY, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol. 2021;7(5):614–27.CrossRefPubMed
4.
Zurück zum Zitat De Potter T, et al. Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation. Eur Heart J. 2021;42:380. De Potter T, et al. Acute safety and performance outcomes from the inspIRE trial using a novel pulsed field ablation system for the treatment of paroxysmal atrial fibrillation. Eur Heart J. 2021;42:380.
5.
Zurück zum Zitat Verma A, et al. First-in-human experience and acute procedural outcomes using a novel pulsed field ablation system: the PULSED AF Pilot Trial. Circ Arrhythm Electrophysiol. 2022;15(1): e010168.CrossRefPubMed Verma A, et al. First-in-human experience and acute procedural outcomes using a novel pulsed field ablation system: the PULSED AF Pilot Trial. Circ Arrhythm Electrophysiol. 2022;15(1): e010168.CrossRefPubMed
6.
Zurück zum Zitat Füting A, et al. CA-536–04 Six-month follow-up of first real-world experience with pulmonary vein isolation using pulsed field ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2022;19(5 Supplement):S92–3.CrossRef Füting A, et al. CA-536–04 Six-month follow-up of first real-world experience with pulmonary vein isolation using pulsed field ablation for paroxysmal atrial fibrillation. Heart Rhythm. 2022;19(5 Supplement):S92–3.CrossRef
7.
Zurück zum Zitat Reddy VY, et al. Coronary arterial spasm during pulsed field ablation to treat atrial fibrillation. Circulation. 0(0):10.1161/CIRCULATIONAHA.122.061497. Reddy VY, et al. Coronary arterial spasm during pulsed field ablation to treat atrial fibrillation. Circulation. 0(0):10.1161/CIRCULATIONAHA.122.061497.
8.
Zurück zum Zitat Zyl MV, et al. Reversible atrioventricular conduction impairment following bipolar nanosecond electroporation of the interventricular septum. JACC: Clin Electrophysiol. 2021;7(2):255–7.PubMed Zyl MV, et al. Reversible atrioventricular conduction impairment following bipolar nanosecond electroporation of the interventricular septum. JACC: Clin Electrophysiol. 2021;7(2):255–7.PubMed
10.
Zurück zum Zitat Reddy VY, et al. Lattice-tip focal ablation catheter that toggles between radiofrequency and pulsed field energy to treat atrial fibrillation: a first-in-human trial. Circ Arrhythm Electrophysiol. 2020;13(6):e008718.CrossRefPubMed Reddy VY, et al. Lattice-tip focal ablation catheter that toggles between radiofrequency and pulsed field energy to treat atrial fibrillation: a first-in-human trial. Circ Arrhythm Electrophysiol. 2020;13(6):e008718.CrossRefPubMed
11.
Zurück zum Zitat Yavin H, et al. Pulsed field ablation using a lattice electrode for focal energy delivery. Circ: Arrhythmia Electrophysiol. 2020;13(6):e008580. Yavin H, et al. Pulsed field ablation using a lattice electrode for focal energy delivery. Circ: Arrhythmia Electrophysiol. 2020;13(6):e008580.
12.
Zurück zum Zitat DeSimone CV, et al. Novel balloon catheter device with pacing, ablating, electroporation, and drug-eluting capabilities for atrial fibrillation treatment–preliminary efficacy and safety studies in a canine model. Transl Res. 2014;164(6):508–14.CrossRefPubMedPubMedCentral DeSimone CV, et al. Novel balloon catheter device with pacing, ablating, electroporation, and drug-eluting capabilities for atrial fibrillation treatment–preliminary efficacy and safety studies in a canine model. Transl Res. 2014;164(6):508–14.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Kapa S, DeSimone CV, Asirvatham SJ. Innervation of the heart: an invisible grid within a black box. Trends Cardiovasc Med. 2016;26(3):245–57.CrossRefPubMed Kapa S, DeSimone CV, Asirvatham SJ. Innervation of the heart: an invisible grid within a black box. Trends Cardiovasc Med. 2016;26(3):245–57.CrossRefPubMed
Metadaten
Titel
Pulsed field electroporation for pulmonary vein isolation—continued innovation to improve our atrial fibrillation armamentarium
verfasst von
Robert C. Ward
Christopher V. DeSimone
Publikationsdatum
28.11.2022
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 7/2023
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-022-01418-3

Weitere Artikel der Ausgabe 7/2023

Journal of Interventional Cardiac Electrophysiology 7/2023 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.